DBVT Q2 2025 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$5M

Operating Income

-$43M

Net Income

-$42M

EPS (Diluted)

$-1.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$143M

Total Liabilities

$57M

Stockholders' Equity

$86M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5M	-$4M	-11.3%
Operating Income	-$43M	-$35M	-23.3%
Net Income	-$42M	-$33M	-28.2%